Description

Pharmacokinetics and Pharmacodynamics:

Alfacalcidol, the active ingredient in our formulation, is a synthetic derivative of vitamin D. Once ingested, alfacalcidol undergoes rapid conversion in the liver to its active form, calcitriol. Calcitriol plays a crucial role in calcium homeostasis by enhancing intestinal absorption of calcium and phosphate, promoting bone mineralization, and regulating parathyroid hormone secretion.

Drug Classification:

Alfacalcidol is classified as a vitamin D analog and is commonly used as a vitamin D supplement. It is indicated for the treatment of various disorders related to calcium metabolism, including osteoporosis, hypocalcemia, and renal osteodystrophy.

Formulations:

Our Alfacalcidol Range is available in tablet form, with each tablet containing 0.5 mg of alfacalcidol. Each pack contains 10 tablets, providing a convenient supply for effective management of bone health and related conditions.

Indications:

Alfacalcidol is indicated for the treatment and prevention of the following conditions:

Osteoporosis: Alfacalcidol helps improve bone mineral density and reduce the risk of fractures in individuals with osteoporosis.

Hypocalcemia: It is used to correct low levels of calcium in the blood, which may occur due to various factors, including vitamin D deficiency, kidney disease, or malabsorption disorders.

Renal Osteodystrophy: Alfacalcidol is beneficial for patients with chronic kidney disease who develop bone abnormalities due to impaired kidney function.

Usage:

Alfacalcidol tablets should be taken orally, preferably with food to enhance absorption. The dosage regimen may vary depending on the patient’s age, medical condition, and response to treatment. It is essential to follow the prescribed treatment plan and adhere to regular follow-up appointments for monitoring and dose adjustments as necessary.

Dosage:

The recommended dosage of alfacalcidol for adults varies depending on the indication and severity of the condition. For osteoporosis prevention, a typical dose may range from 0.25 to 1 microgram daily. In cases of hypocalcemia or renal osteodystrophy, higher doses may be required, with adjustments made based on serum calcium levels and clinical response.

Side Effects:

Common side effects of alfacalcidol may include hypercalcemia, hypercalciuria, gastrointestinal disturbances (such as nausea, vomiting, or constipation), headache, and dizziness. Rare but serious adverse effects may include renal impairment, calcification of soft tissues, and cardiac arrhythmias. Patients should be monitored closely for signs of hypercalcemia and other adverse reactions, and healthcare providers should be notified of any concerning symptoms.

Conclusion:

Choose AIT Pharmaceuticals Division for superior bone health support with our Alfacalcidol Range. Empower yourself to combat osteoporosis, hypocalcemia, and renal osteodystrophy effectively with our proven medication. Trust AIT Pharmaceuticals Division for personalized care and reliable treatment options tailored to your bone health needs.